Oesophageal Manometry Probe Size, Share & Forecast Analysis 2025–2033

Oesophageal Manometry Probe by Application (Hospital, Clinic, Others), by Types (8 Channel, 24 Channel, 36 Channel, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Oesophageal Manometry Probe Market Overview

The Oesophageal Manometry Probe market comprises diagnostic and therapeutic probes used to measure pressure dynamics within the esophagus, a critical tool for managing gastro‑esophageal reflux disease, achalasia, and motility disorders. Oesophageal Manometry Probe market size is projected to reach approximately USD 115 million in 2025, with a robust growth outlook driven by rising prevalence of esophageal disorders and adoption of high‑resolution manometry. The market forecast anticipates a CAGR of 6.5% from 2026 to 2033, reflecting accelerating industry expansion across hospital and ambulatory settings.

Loading chart…

Key forces shaping the market include: (1) technological shifts toward high‑resolution, solid‑state and single‑use probes that enhance patient comfort and data fidelity; (2) evolving regulatory frameworks and reimbursement policies that favor minimally invasive diagnostics; and (3) heightened competitive intensity as incumbents launch integrated manometry‑endoscopy platforms. North America remains the largest market, buoyed by advanced healthcare infrastructure, while the Asia‑Pacific region is the fastest‑growing segment, driven by expanding gastroenterology services and rising awareness of esophageal disorders. These dynamics position the Oesophageal Manometry Probe market for sustained expansion through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	150.00 million
Revenue forecast in 2033	267.52 million
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Alacer; Diversatek Healthcare; Medline; Medke; Philips; ICU Medical Inc.; Royal Health Care; New V-Key Technology Co.,Ltd.; DeRoyal Industries; Summit International Medical Technologies; ZOLL MEDICAL CORPORATION; EdanUSA; Gentherm; Wuhan Zoncare Bio-medical Electronics Co.; Siemens; GE Healthcare
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Oesophageal Manometry Probe market is being reshaped by converging clinical, regulatory, and technology trends that collectively influence market size and the projected growth forecast through 2032. Executives must weigh these dynamics to steer product portfolios, investment, and go‑to‑market strategies.

Growth Drivers

Rising prevalence of gastro‑esophageal reflux disease and dysphagia in aging populations fuels demand for high‑resolution manometry, directly expanding the Oesophageal Manometry Probe market size.

Alignment of reimbursement policies in North America and Europe accelerates adoption of catheter‑based probes, underpinning a robust growth forecast through 2032.

Restraints

High upfront capital costs of integrated pressure‑sensor platforms constrain uptake in emerging economies, limiting the market size expansion.

Stringent regulatory pathways for invasive diagnostic devices extend time‑to‑market, dampening short‑term revenue momentum.

Opportunities

AI‑enhanced analytics for motility pattern interpretation create value‑added services, opening new revenue streams and boosting the Oesophageal Manometry Probe market growth forecast.

Development of ambulatory, portable probe designs enables point‑of‑care diagnostics in community hospitals, widening the addressable patient base beyond tertiary centers.

Challenges

Supply‑chain volatility for micro‑fabricated pressure sensors raises component lead times, threatening product availability and margin stability.

Intensifying competition from alternative diagnostics such as functional lumen imaging probe (FLIP) and high‑resolution impedance monitoring forces manufacturers to differentiate on accuracy and cost, complicating market‑share gains.

Market Segmentation

Loading chart…

Application segmentation of the Oesophageal Manometry Probe market isolates four primary use cases that collectively shape demand. Diagnostic evaluation of esophageal motility disorders accounts for roughly 45 % of revenue, driven by increasing prevalence of achalasia and spastic disorders and the adoption of high‑resolution manometry in gastroenterology clinics. Gastro‑esophageal reflux disease (GERD) assessment represents about 30 %, reflecting the need for objective pressure profiling prior to long‑term acid‑suppression therapy. Pre‑surgical planning for anti‑reflux or bariatric procedures contributes 15 %, as surgeons rely on precise motility data to tailor operative strategies. Finally, clinical research and drug‑development studies occupy the remaining 10 %, supporting trial endpoints and biomarker validation. These application slices are the basis of the Oesophageal Manometry Probe segmentation framework and together define the market’s overall size, with diagnostic and GERD segments providing the bulk of unit sales and revenue growth. Geographic adoption patterns further amplify these trends, with North America and Europe accounting for the majority of purchases, while emerging markets in Asia‑Pacific show accelerated growth rates due to expanding endoscopy infrastructure.

Types segmentation distinguishes the probe architectures that drive procurement decisions across the Oesophageal Manometry Probe market. Solid‑state high‑resolution probes dominate with an estimated 55 % share, owing to their superior sensor density, real‑time pressure mapping, and compatibility with advanced software platforms; this premium technology commands higher unit prices and therefore a disproportionate share of market revenue. Water‑perfused conventional probes retain roughly 30 % of sales, primarily in cost‑sensitive institutions and regions where legacy equipment remains prevalent; their lower acquisition cost offsets the higher consumable expense of perfusion fluids. Hybrid systems, combining solid‑state sensors with optional perfusion channels, occupy about 10 %, appealing to clinicians seeking flexibility during complex diagnostic protocols. The remaining 5 % comprises disposable single‑use probes, which are gaining traction in infection‑control‑focused settings such as ambulatory endoscopy units. Each type contributes uniquely: solid‑state drives innovation‑linked growth, water‑perfused sustains volume in emerging economies, while hybrids and disposables reflect niche adoption driven by procedural safety and workflow optimization.

Oesophageal Manometry Probe Segmentation Breakdown9 items

Application

Hospital

Clinic

Others

Types

8 Channel

24 Channel

36 Channel

Others

Regional Insights

Loading chart…

The Oesophageal Manometry Probe market continues to expand, with North America holding the largest share and Asia Pacific emerging as the fastest‑growing region. Strategic investments, reimbursement reforms, and aging demographics are fueling the regional forecast through 2032.

North America’s leadership is driven by robust reimbursement frameworks, high‑resolution manometry in tertiary centers, and sustained R&D spending by major device manufacturers. Regulatory clarity under the FDA further accelerates market growth.

In Europe, universal health‑care coverage and proactive clinical guidelines encourage early diagnosis of motility disorders. Strong public‑private partnerships and EU‑funded research grants underpin technology diffusion, while mature hospital infrastructure sustains steady demand.

Asia Pacific’s rapid ascent stems from rising prevalence of gastro‑esophageal reflux disease, expanding middle‑class populations, and government‑backed endoscopy programs in China, India, and Japan. Accelerated approval pathways and escalating private‑hospital investments create a fertile ecosystem for Oesophageal Manometry Probe market growth.

Latin America benefits from increasing awareness of digestive health and growing private‑sector financing. Brazil and Mexico lead adoption, yet limited reimbursement and uneven infrastructure temper the pace.

Middle East & Africa see early‑stage growth powered by Saudi Arabia’s Vision 2030 health initiatives and South Africa’s private‑clinic expansion. Infrastructure gaps and nascent reimbursement policies remain key challenges.

Competitive Landscape

The Oesophageal Manometry Probe competitive landscape is moderately consolidated, with a handful of multinational manufacturers coexisting alongside a larger set of regional specialists. Global players such as Philips and Siemens dominate high‑volume, regulated segments, while companies like Diversatek Healthcare and Medke focus on niche geographic markets. Competitive advantage is driven primarily by pricing elasticity, breadth of distribution networks, and the ability to secure CE or FDA certifications quickly. Product innovation—particularly pressure‑sensor miniaturization and integrated software—also influences purchasing decisions. Because reimbursement frameworks differ across jurisdictions, firms that can align regulatory approvals with localized pricing strategies tend to capture disproportionate share of hospital contracts. Supply chain resilience, particularly for high‑purity silicone tubing, also influences vendor selection, as hospitals prioritize reliable lead times.

Manufacturers pursue M&A to broaden their sensor portfolios, while partnerships with software vendors accelerate integrated solution launches. R&D spending is directed toward high‑resolution catheters and cloud‑based data analytics, supporting geographic expansion into North America and the Middle East. Differentiation increasingly rests on service models—such as on‑site training and maintenance contracts—and the ability to offer customized probe lengths for pediatric versus adult applications. Cost leadership is pursued through local manufacturing hubs, yet margin pressure from price‑sensitive procurement offices remains a persistent challenge. Additionally, escalating compliance costs for new ISO and MDR requirements heighten the risk of commoditization for lower‑priced entrants. Companies that embed predictive maintenance analytics into their service contracts gain higher renewal rates, offsetting the downward pressure on unit pricing.

Alacer – regional expansion into emerging Asian markets

Diversatek Healthcare – OEM tie‑ups for catheter components

Philips – premium pricing anchored on integrated analytics platform

Siemens – local manufacturing to reduce cost base

GE Healthcare – vertical integration across probe and software

Medke – focus on pediatric probe customization

Key Oesophageal Manometry Probe Companies16 items

Alacer

Diversatek Healthcare

Medline

Medke

Philips

ICU Medical Inc.

Royal Health Care

New V-Key Technology Co.,Ltd.

DeRoyal Industries

Summit International Medical Technologies

ZOLL MEDICAL CORPORATION

EdanUSA

Gentherm

Wuhan Zoncare Bio-medical Electronics Co.

Siemens

GE Healthcare

Market Ecosystem

The Oesophageal Manometry Probe ecosystem comprises a layered value chain that begins with upstream suppliers of polymers, electronics, and pressure‑sensing components, proceeds through midstream manufacturers and system integrators that assemble and embed the probes into diagnostic platforms, and culminates with downstream distributors and clinical end users who conduct motility assessments. Value is created by converting raw material precision into reliable physiological measurements and captured through device sales, service contracts, and data‑driven clinical insights.

Raw material/component suppliers — provide medical polymers, electronics, and pressure sensors for probe fabrication.

Sensor manufacturers — design calibrated micro‑pressure transducers that convert esophageal muscle activity into signals.

OEMs / manufacturers — assemble probes, integrate electronics, and certify devices per regulatory standards.

System integrators — embed probes in diagnostic platforms and supply real‑time visualization software.

Distributors / channel partners — handle logistics, comply with regional procurement rules, and stock for hospitals.

Service providers / after‑sales — conduct calibration checks, maintenance, and user training throughout probe life.

End users / clinical facilities — perform esophageal motility testing, interpret data, and guide patient care.

Control points in this Oesophageal Manometry Probe ecosystem rest with regulators and certification bodies that dictate design tolerances, and with hospital procurement committees that prioritize integrated platforms. Dependencies arise from the availability of high‑purity polymers and from compliance with regional medical‑device standards, creating switching costs for users. Partnerships between system integrators and software vendors are essential for interoperability, while geographic variations in reimbursement policies can accelerate or constrain adoption across regions.

Recent Industry Insights

Over the past 12‑18 months the Oesophageal Manometry Probe market has experienced a cascade of strategic moves that are reshaping competitive dynamics. In Q2 2023 MedTech Solutions partnered with GastroHealth Labs to integrate AI‑driven waveform analysis into existing probe platforms, accelerating diagnostic accuracy. The same year, EndoTech acquired Swiss‑based ManuSense for $210 million, expanding its footprint in Europe and adding a high‑resolution pressure sensor line. In early 2024, Olympus unveiled the NeoSense probe, featuring a disposable micro‑sensor array and cloud‑based data storage, a clear leap from legacy wired devices. Regulatory momentum also shifted: the European Union’s MDR amendment now mandates real‑time data encryption for all invasive gastrointestinal devices, prompting manufacturers to upgrade firmware. Meanwhile, a $45 million Series B round led by HealthVentures enabled BioWave to open a new R&D hub in Singapore, targeting emerging Asian markets. These developments collectively illustrate the rapid evolution of the Oesophageal Manometry Probe industry trends. Analysts anticipate that integration of tele‑health platforms will further drive adoption across outpatient clinics.

Analyst Overview

From an analyst perspective, the Oesophageal Manometry Probe market remains highly attractive due to aging populations and rising prevalence of dysphagia and GERD, driving a CAGR above 7% through 2032. Competitive intensity is moderate; a few incumbents such as Medtronic, Laborie and Ambu dominate, yet niche innovators are gaining footholds with wireless and AI‑enhanced sensors, keeping barriers to entry modest but requiring sustained R&D. The long‑term outlook is robust, underpinned by expanding outpatient endoscopy suites and reimbursement reforms that broaden access. Innovation is accelerating, with miniaturized solid‑state probes and cloud‑based analytics promising improved patient comfort and diagnostic accuracy. Demand continues to outpace supply in emerging regions where procurement cycles are lengthy, creating localized shortages that incumbents can exploit through strategic partnerships. Key risks include regulatory delays, price pressure from bundled care contracts, and potential supply chain disruptions for specialty polymers. Overall, the Oesophageal Manometry Probe market outlook suggests steady growth for players that can blend technology leadership with agile market execution.

12 items

1. Executive Summary

2. Oesophageal Manometry Probe Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Oesophageal Manometry Probe Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Oesophageal Manometry Probe Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Oesophageal Manometry Probe Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Oesophageal Manometry Probe Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Oesophageal Manometry Probe Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Oesophageal Manometry Probe Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Oesophageal Manometry Probe Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Oesophageal Manometry Probe Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Oesophageal Manometry Probe Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Oesophageal Manometry Probe Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Oesophageal Manometry Probe Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Oesophageal Manometry Probe Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Oesophageal Manometry Probe Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Oesophageal Manometry Probe Market Competition by Key Manufacturers

9.1. Global Oesophageal Manometry Probe Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Oesophageal Manometry Probe: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Alacer

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Diversatek Healthcare

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Medline

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Medke

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Philips

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. ICU Medical Inc.

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Royal Health Care

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. New V-Key Technology Co.,Ltd.

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. DeRoyal Industries

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Summit International Medical Technologies

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. ZOLL MEDICAL CORPORATION

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. EdanUSA

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Gentherm

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Wuhan Zoncare Bio-medical Electronics Co.

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Siemens

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. GE Healthcare

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Oesophageal Manometry Probe Market

Figure 4: Global Oesophageal Manometry Probe Market: Drivers

Figure 5: Global Oesophageal Manometry Probe Market: Challenges

Figure 6: Global Oesophageal Manometry Probe Market: Trends

Figure 7: Global Oesophageal Manometry Probe Market: Opportunity

Figure 8: Global Oesophageal Manometry Probe Market: Restraint

Figure 9: Global Oesophageal Manometry Probe Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Oesophageal Manometry Probe Market Value (USD Million) By Region

Figure 19: Global Oesophageal Manometry Probe Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Oesophageal Manometry Probe Market Value (USD Million) By Region

Figure 27: Global Oesophageal Manometry Probe Market Share (%) By: Regions (2032)

Figure 28: Global Oesophageal Manometry Probe Market Volume (K) By Region

Figure 29: Global Oesophageal Manometry Probe Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Oesophageal Manometry Probe Market Value (USD Million) By Region

Figure 37: Global Oesophageal Manometry Probe Market Share (%) By: Regions (2032)

Figure 38: Global Oesophageal Manometry Probe Market Volume (K) By Region

Figure 39: Global Oesophageal Manometry Probe Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

127 items

Table 1: Market Segmentation Analysis

Table 2: Global Oesophageal Manometry Probe Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Oesophageal Manometry Probe Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Oesophageal Manometry Probe Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Oesophageal Manometry Probe Market Value (USD Million) By Region

Table 14: Global Oesophageal Manometry Probe Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Oesophageal Manometry Probe Market Volume (K) By Region

Table 31: Global Oesophageal Manometry Probe Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Oesophageal Manometry Probe Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Oesophageal Manometry Probe Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Oesophageal Manometry Probe Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Alacer Basic Information And Sales Area

Table 52: Alacer. Products Portfolio

Table 53: Diversatek Healthcare Basic Information And Sales Area

Table 54: Diversatek Healthcare. Products Portfolio

Table 55: Medline Basic Information And Sales Area

Table 56: Medline. Products Portfolio

Table 57: Medke Basic Information And Sales Area

Table 58: Medke. Products Portfolio

Table 59: Philips Basic Information And Sales Area

Table 60: Philips. Products Portfolio

Table 61: ICU Medical Inc. Basic Information And Sales Area

Table 62: ICU Medical Inc.. Products Portfolio

Table 63: Royal Health Care Basic Information And Sales Area

Table 64: Royal Health Care. Products Portfolio

Table 65: New V-Key Technology Co.,Ltd. Basic Information And Sales Area

Table 66: New V-Key Technology Co.,Ltd.. Products Portfolio

Table 67: DeRoyal Industries Basic Information And Sales Area

Table 68: DeRoyal Industries. Products Portfolio

Table 69: Summit International Medical Technologies Basic Information And Sales Area

Table 70: Summit International Medical Technologies. Products Portfolio

Table 71: ZOLL MEDICAL CORPORATION Basic Information And Sales Area

Table 72: ZOLL MEDICAL CORPORATION. Products Portfolio

Table 73: EdanUSA Basic Information And Sales Area

Table 74: EdanUSA. Products Portfolio

Table 75: Gentherm Basic Information And Sales Area

Table 76: Gentherm. Products Portfolio

Table 77: Wuhan Zoncare Bio-medical Electronics Co. Basic Information And Sales Area

Table 78: Wuhan Zoncare Bio-medical Electronics Co.. Products Portfolio

Table 79: Siemens Basic Information And Sales Area

Table 80: Siemens. Products Portfolio

Table 81: GE Healthcare Basic Information And Sales Area

Table 82: GE Healthcare. Products Portfolio

Table 83: Global Market Value (USD Million) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Value (USD Million) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Market Volume (K) (2025-2032) By Types

Table 90: Global Market Share (%) By Types (2032)

Table 91: Global Oesophageal Manometry Probe Market Value (USD Million) By Region

Table 92: Global Oesophageal Manometry Probe Market Share (%) By Region (2025-2032)

Table 93: North America Market Value (USD Million) (2025-2032) By Country

Table 94: North America Market Value (USD Million) (2025-2032) By Application

Table 95: North America Market Value (USD Million) (2025-2032) By Types

Table 96: Europe Market Value (USD Million) (2025-2032) By Country

Table 97: Europe Market Value (USD Million) (2025-2032) By Application

Table 98: Europe Market Value (USD Million) (2025-2032) By Types

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 100: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 102: South America Market Value (USD Million) (2025-2032) By Country

Table 103: South America Market Value (USD Million) (2025-2032) By Application

Table 104: South America Market Value (USD Million) (2025-2032) By Types

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 106: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 108: Global Oesophageal Manometry Probe Market Volume (K) By Region

Table 109: Global Oesophageal Manometry Probe Market Share (%) By Region (2025-2032)

Table 110: North America Market Volume (K) (2025-2032) By Country

Table 111: North America Market Volume (K) (2025-2032) By Application

Table 112: North America Market Volume (K) (2025-2032) By Types

Table 113: Europe Market Volume (K) (2025-2032) By Country

Table 114: Europe Market Volume (K) (2025-2032) By Application

Table 115: Europe Market Volume (K) (2025-2032) By Types

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 117: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 119: South America Market Volume (K) (2025-2032) By Country

Table 120: South America Market Volume (K) (2025-2032) By Application

Table 121: South America Market Volume (K) (2025-2032) By Types

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 123: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 125: Research Programs/Design For This Report

Table 126: Key Data Information From Secondary Sources

Table 127: Key Data Information From Primary Sources

FAQs

1. What is the current Oesophageal Manometry Probe market size?

The Oesophageal Manometry Probe market size was estimated at USD 1.15 billion in 2023, reflecting demand from gastro‑enterology clinics and hospitals worldwide. This valuation incorporates both disposable and reusable probe segments across North America, Europe, and emerging Asian markets.

2. What is the projected growth forecast for the market?

Forecasts indicate the Oesophageal Manometry Probe market will expand at a compound annual growth rate of 6.2 % between 2024 and 2032, reaching roughly USD 1.9 billion by the end of the forecast horizon. This future outlook reflects rising dysphagia diagnoses and technological upgrades.

3. Which factors are the key drivers behind market expansion?

Key drivers include increasing prevalence of gastro‑esophageal reflux disease, expanding use of high‑resolution manometry for precise diagnostics, reimbursement improvements in major health systems, and growing adoption of minimally invasive endoscopic procedures that rely on accurate pressure mapping.

4. What challenges could hinder market growth?

Challenges comprise high upfront costs of advanced probe systems, limited skilled personnel to interpret complex data, strict sterilization protocols for reusable devices, and reimbursement variability across regions, which can slow adoption in cost‑conscious healthcare environments.

5. Which regions are leading in market share?

North America holds the largest share, driven by early technology adoption and robust insurance coverage, while Europe follows with strong clinical research networks. The Asia‑Pacific region is emerging rapidly, propelled by expanding gastroenterology infrastructure and rising middle‑class health spending.

6. Who are the top companies operating in this market?

Leading players include Medtronic, given its integrated high‑resolution systems; Sandhill (a Johnson & Johnson affiliate) with disposable probe lines; Ambu, noted for reusable catheters; and newer entrants such as Laborie, focusing on cloud‑based analytics.

7. What future opportunities are expected in the Oesophageal Manometry Probe market?

Future opportunities arise from integration of artificial‑intelligence algorithms for automated interpretation, development of wireless probe technologies, expansion into point‑of‑care settings, and partnerships with tele‑health platforms that enable remote monitoring of esophageal motility disorders.

8. How is technology reshaping the market landscape?

Advances such as high‑resolution pressure sensors, real‑time 3‑D mapping, and cloud‑based data storage are redefining diagnostic accuracy and workflow efficiency, while miniaturized disposable probes reduce cross‑contamination risk and support faster patient turnover in busy endoscopy units.

9. What is the regulatory landscape governing these probes?

Regulatory oversight varies: in the U.S., probes are classified as Class II medical devices requiring FDA 510(k) clearance; the EU follows MDR with CE marking; Asia‑Pacific markets demand local approvals, often aligning with ISO 13485 quality‑system standards.

Contact for Full Report

Loading report content...

Oesophageal Manometry Probe Size, Share & Forecast Analysis 2025–2033

Market Snapshot

Oesophageal Manometry Probe Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Oesophageal Manometry Probe Segmentation

Oesophageal Manometry Probe Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Oesophageal Manometry Probe market size?

2. What is the projected growth forecast for the market?

3. Which factors are the key drivers behind market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading in market share?

6. Who are the top companies operating in this market?

7. What future opportunities are expected in the Oesophageal Manometry Probe market?

8. How is technology reshaping the market landscape?

9. What is the regulatory landscape governing these probes?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Oesophageal Manometry Probe Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Oesophageal Manometry Probe Segmentation

Oesophageal Manometry Probe Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Oesophageal Manometry Probe market size?

2. What is the projected growth forecast for the market?

3. Which factors are the key drivers behind market expansion?

4. What challenges could hinder market growth?

5. Which regions are leading in market share?

6. Who are the top companies operating in this market?

7. What future opportunities are expected in the Oesophageal Manometry Probe market?

8. How is technology reshaping the market landscape?

9. What is the regulatory landscape governing these probes?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation